Tumor-infiltrating FoxP3(+) Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.

Tumor-infiltrating FoxP3(+) Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis.
复制标题

DOI:
10.18632/oncotarget.17722
复制
发表时间:
2017-09-26
期刊:
影响因子:
--
通讯作者:
Wang S
Wang S
中科院分区:
其他
文献类型:
--
作者:
Hu G;Li Z;Wang S

文献摘要

参考文献

被引文献

相似文献

Foxp3+调节性T细胞(FoxP3+Tregs)被认为是免疫逃逸和肿瘤进展的关键介质。然而,FoxP3+Tregs在人类结直肠癌(CRC)中的作用仍存在争议。在这里,我们进行了一项荟萃分析,包括17项已发表的研究,涉及来自PubMed和EBSCO的3811名患者,以评估肿瘤浸润性FoxP3+Tregs对人类结直肠癌预后的影响。研究发现,FoxP3+Tregs的表达与患者1、3、5、10年总生存期(OS)呈显著正相关,而与1、3、5年无瘤生存期(DFS)无明显相关性。有趣的是,在按肿瘤内FoxP3+Tregs渗入的间隔进行的分层分析中,FoxP3+Tregs侵入间质间质明显改善了3年和5年的OS,而当FoxP3+Tregs仅渗透到上皮内时,OS没有改善。此外,FoxP3+Tregs同时侵犯上皮内和间质与结直肠癌的TNM分期呈显著负相关。结论:肿瘤内高密度的FoxP3+Tregs尤其是间质内高密度的FoxP3+Tregs有助于结直肠癌的预后,提示FoxP3+Tregs是判断结直肠癌预后的有价值的指标之一。
FoxP3+ regulatory T cells (FoxP3+ Tregs) are considered to be a key mediator in immune escape and tumor progression. However, the role of FoxP3+ Tregs in human colorectal cancer (CRC) remains controversial. Herein, we conducted a meta-analysis including 17 published studies with 3811 patients identified from PubMed and EBSCO to assess the prognostic impact of tumor-infiltrating FoxP3+ Tregs in human CRC. We found FoxP3+ Tregs infiltrating into both intraepithelium and stroma within tumor were significantly positively correlated with 1, 3, 5 and 10-year overall survival (OS), but not with 1, 3, 5-year disease-free survival (DFS) of patients. Interestingly, in stratified analyses by compartments within tumor FoxP3+ Tregs infiltrating into, FoxP3+ Tregs invading stromal compartment significantly improved 3 and 5-year OS, yet OS wasn’t improved when FoxP3+ Tregs infiltrated into intraepithelium only. Furthermore, FoxP3+ Tregs invading both intraepithelium and stroma significantly inversely correlated with TNM stage of CRC. In conclusion, High density of FoxP3+ Tregs within tumor especially at stromal compartment leads to a favorable outcome in CRC, implicating FoxP3+ Tregs are one of valuable indexes for prognostic prediction in human CRC.
DOI: 10.1158/0008-5472.can-10-2907
发表时间: 2011-02-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Tosolini, Marie;Kirilovsky, Amos;Galon, Jerome
通讯作者: Galon, Jerome
DOI: 10.1016/j.cct.2006.04.004
发表时间: 2007-02-01
影响因子: 2.2
作者:
DerSimonian, Rebecca;Kacker, Raghu
通讯作者: Kacker, Raghu
DOI: 10.1200/jco.2008.18.7229
发表时间: 2009-01-10
影响因子: 45.3
作者:
Salama, Paul;Phillips, Michael;Iacopetta, Barry
通讯作者: Iacopetta, Barry
DOI: 10.1371/journal.pone.0053630
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Kim M;Grimmig T;Grimm M;Lazariotou M;Meier E;Rosenwald A;Tsaur I;Blaheta R;Heemann U;Germer CT;Waaga-Gasser AM;Gasser M
通讯作者: Gasser M
DOI: 10.1186/1471-2407-14-486
发表时间: 2014-07-05
期刊: BMC cancer
影响因子: 3.8
作者:
Reimers MS;Engels CC;Putter H;Morreau H;Liefers GJ;van de Velde CJ;Kuppen PJ
通讯作者: Kuppen PJ